Send this to a friend

SEC charges Marlborough's Lemelson Capital with fraud

A Marlborough hedge fund adviser and his investment firm are being charged by the U.S. Securities and Exchange Commission with profiting more than $1.3 million after driving down the price of a California pharmaceutical company.
In a civil complaint filed in federal court Wednesday, the SEC charged Gregory Lemelson of Lemelson Capital Management with issuing false information about Ligand Pharmaceuticals after Lemelson took a short position in the ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media